Ending deaths from HIV-related cryptococcal meningitis by 2030.
作者信息
Shroufi Amir, Chiller Tom, Jordan Alex, Denning David W, Harrison Thomas S, Govender Nelesh P, Loyse Angela, Baptiste Solange, Rajasingham Radha, Boulware David R, Ribeiro Isabela, Jarvis Joseph N, Van Cutsem Gilles
机构信息
CDC Foundation, Cape Town, South Africa.
Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
出版信息
Lancet Infect Dis. 2021 Jan;21(1):16-18. doi: 10.1016/S1473-3099(20)30909-9. Epub 2020 Nov 30.
Abstract
摘要
相似文献
1
Ending deaths from HIV-related cryptococcal meningitis by 2030.到2030年终结因与艾滋病相关的隐球菌性脑膜炎导致的死亡。
Lancet Infect Dis. 2021 Jan;21(1):16-18. doi: 10.1016/S1473-3099(20)30909-9. Epub 2020 Nov 30.
2
Treating cryptococcal meningitis in people with HIV.治疗感染HIV的人群中的隐球菌性脑膜炎。
BMJ. 2013 Apr 10;346:f2203. doi: 10.1136/bmj.f2203.
3
Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis.抗逆转录病毒药物推广，抗真菌药物缩减：隐球菌性脑膜炎的治疗可及性
Lancet Infect Dis. 2005 Sep;5(9):530-1. doi: 10.1016/S1473-3099(05)70197-3.
4
Current approach to the acute management of cryptococcal infections.隐球菌感染急性处理的当前方法。
J Infect. 2000 Jul;41(1):18-22. doi: 10.1053/jinf.2000.0696.
5
Comparison of Early Fungicidal Activity and Mortality Between Daily Liposomal Amphotericin B and Daily Amphotericin B Deoxycholate for Cryptococcal Meningitis.每日脂质体两性霉素B与每日去氧胆酸两性霉素B治疗新型隐球菌性脑膜炎的早期杀菌活性及死亡率比较
Clin Infect Dis. 2025 Feb 5;80(1):153-159. doi: 10.1093/cid/ciae326.
6
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.获得性免疫缺陷综合征相关隐球菌性脑膜炎的治疗。美国国立过敏和传染病研究所真菌病研究组及艾滋病临床试验组。
N Engl J Med. 1997 Jul 3;337(1):15-21. doi: 10.1056/NEJM199707033370103.
7
Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.氟胞嘧啶与高剂量氟康唑联合治疗与氟康唑单药治疗隐球菌性脑膜炎的随机试验：来自马拉维的研究。
Clin Infect Dis. 2010 Feb 1;50(3):338-44. doi: 10.1086/649861.
8
Access to flucytosine for HIV-infected patients with cryptococcal meningitis – an urgent need.为感染HIV的隐球菌性脑膜炎患者提供氟胞嘧啶——一项迫切需求。
S Afr Med J. 2014 Sep;104(9):594-5. doi: 10.7196/samj.8713.
9
Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.获得性免疫缺陷综合征患者的隐球菌性脑膜炎
Pharmacotherapy. 1996 Jul-Aug;16(4):547-61.
10
Updating guidance for preventing and treating cryptococcal disease: how evidence and decisions interface.更新隐球菌病防治指南：证据与决策的交互作用
Cochrane Database Syst Rev. 2018 Nov 30;11(11):ED000130. doi: 10.1002/14651858.ED000130.
引用本文的文献
1
The role of uncharacterized protein Taf1 in regulating ATP levels and virulence of Cryptococcus neoformans.未鉴定蛋白Taf1在调节新型隐球菌ATP水平和毒力中的作用。
BMC Microbiol. 2025 Aug 5;25(1):480. doi: 10.1186/s12866-025-04207-w.
2
Evidence for the role of Irk2 and Irk5 in ATP and metabolism regulation in .关于Irk2和Irk5在……中对ATP和代谢调节作用的证据。 （注：原文句末不完整，推测是某个具体的研究对象未完整给出）
Front Cell Infect Microbiol. 2025 Jun 18;15:1600041. doi: 10.3389/fcimb.2025.1600041. eCollection 2025.
3
Development and Spatial External Validation of a Predictive Model of Survival Based on Random Survival Forest Analysis for People Living With HIV and AIDS After Highly Active Antiretroviral Therapy in China: Retrospective Cohort Study.基于随机生存森林分析的中国接受高效抗逆转录病毒治疗的艾滋病毒/艾滋病患者生存预测模型的开发与空间外部验证：回顾性队列研究
J Med Internet Res. 2025 Jun 2;27:e71257. doi: 10.2196/71257.
4
Transcription Factors Fzc9 and Pdr802 Regulate ATP Levels and Metabolism in .转录因子Fzc9和Pdr802调节……中的ATP水平和代谢
Int J Mol Sci. 2025 Feb 20;26(5):1824. doi: 10.3390/ijms26051824.
5
Screening for cryptococcal antigenemia and meningeal cryptococcosis, genetic characterization of Cryptococcus neoformans in asymptomatic patients with advanced HIV disease in Kinshasa, Democratic Republic of Congo.刚果民主共和国金沙萨晚期HIV疾病无症状患者的隐球菌抗原血症和脑膜隐球菌病筛查及新型隐球菌的基因特征分析
Sci Rep. 2024 Dec 2;14(1):29959. doi: 10.1038/s41598-024-80772-w.
6
Diagnostic Performances of an in-House Immunochromatography Test Based on the Monoclonal Antibody 18B7 to Glucuronoxylomannan for Clinical Suspected Cryptococcosis: a Large-Scale Prototype Evaluation in Northern Thailand.基于单克隆抗体 18B7 对葡聚糖检测的家用免疫层析试验在疑似隐球菌病临床诊断中的性能：泰国北部的大型原型评估。
Mycopathologia. 2024 Aug 9;189(5):75. doi: 10.1007/s11046-024-00882-x.
7
Funding for research on cryptococcal disease: an analysis based on the G-finder report.隐球菌病研究资金：基于G-finder报告的分析
IMA Fungus. 2024 Mar 2;15(1):4. doi: 10.1186/s43008-023-00133-6.
8
Heme sensing and trafficking in fungi.真菌中的血红素感知与转运
Fungal Biol Rev. 2023 Mar;43. doi: 10.1016/j.fbr.2022.09.002. Epub 2022 Oct 5.
9
Connecting Cryptococcal Meningitis and Gut Microbiome.连接新型隐球菌性脑膜炎与肠道微生物组。
Int J Mol Sci. 2023 Aug 31;24(17):13515. doi: 10.3390/ijms241713515.
10
Metals and the cell surface of Cryptococcus neoformans.金属与新生隐球菌的细胞表面。
Curr Opin Microbiol. 2023 Aug;74:102331. doi: 10.1016/j.mib.2023.102331. Epub 2023 May 29.
本文引用的文献
1
Time to embrace access programmes for medicines: lessons from the South African flucytosine access programme.是时候接受药品获取方案了：南非氟胞嘧啶获取方案的经验教训。
Int J Infect Dis. 2020 Jun;95:459-461. doi: 10.1016/j.ijid.2020.02.057. Epub 2020 Feb 29.
2
Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis.氟胞嘧啶联合氟康唑治疗非洲新型隐球菌性脑膜炎的成本效果分析：一项多国研究
Clin Infect Dis. 2020 Jan 1;70(1):26-29. doi: 10.1093/cid/ciz163.
3
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.抗真菌药物联合治疗非洲隐球菌性脑膜炎。
N Engl J Med. 2018 Mar 15;378(11):1004-1017. doi: 10.1056/NEJMoa1710922.
4
The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa.南非抗逆转录病毒治疗覆盖率持续增加 10 年，艾滋病毒晚期疾病负担持续存在。
Clin Infect Dis. 2018 Mar 4;66(suppl_2):S118-S125. doi: 10.1093/cid/cix1140.
5
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.HIV 相关隐球菌性脑膜炎的全球疾病负担：最新分析
Lancet Infect Dis. 2017 Aug;17(8):873-881. doi: 10.1016/S1473-3099(17)30243-8. Epub 2017 May 5.
6
Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries.隐球菌性脑膜炎：在资源匮乏国家增加基本抗真菌药物的可及性。
Lancet Infect Dis. 2013 Jul;13(7):629-37. doi: 10.1016/S1473-3099(13)70078-1. Epub 2013 Jun 2.
Zotero 插件